Wright K K - OmicsDI

Show results for

Unknown (4091)
Proteomics (98)
Transcriptomics (78)
Genomics (34)
Metabolomics (13)
Genomic (1)
Models (1)

Organisms

Homo sapiens (135)
Mus musculus (33)
Gallus gallus (3)
Citrobacter rodentium (3)
Escherichia coli (3)
Sus scrofa domesticus (3)
Vigna subterranea (2)
Schizosaccharomyces pombe (2)
Rattus norvegicus (2)
Bos taurus (2)
Danio rerio (2)
Shigella flexneri (2)
Xenopus tropicalis (2)
Serendipita vermifera (1)
Pimephales promelas (1)
Arabidopsis lyrata (1)
Macaca mulatta (1)
Macaca fascicularis (1)
Drosophila melanogaster (1)
Arabidopsis thaliana (1)
Anaeromyces (1)
Chlamydia trachomatis (1)
Haloferax volcanii DS2 (1)
Listeria monocytogenes (1)
Mycobacterium marinum (1)
Neocallimastix sp. G-1 (1)
Piromyces sp. (1)
Plasmodium berghei (1)
Plasmodium falciparum 3D7 (1)
Saccharomyces cerevisiae (1)

Organisms

Homo sapiens (2)
Mus musculus (2)
Zea mays (1)
Escherichia coli (1)

Repository

pride (96)
biostudies-arrayexpress (81)
EGA (23)
MetaboLights (12)
ENA (7)
dbGaP (1)
FAIRDOMHub (1)
geo (1)
GNPS (1)
jPOST (1)
MassIVE (1)

Tissue

Cell culture (39)
Brain (5)
Colon (5)
Heart (5)
Whole body (5)
Blood (3)
Blood plasma (3)
Embryonic stem cell (3)
Macrophage (3)
Blood serum (2)
Bronchoalveolar lavage (2)
Embryo (2)
Epithelial cell (2)
Liver (2)
Lung (2)
Lymph node (2)
Monocyte (2)
Skeletal muscle (2)
Stem cell (2)
Articular cartilage (1)
B cell (1)
Bile (1)
Bile duct (1)
Blood cell (1)
Blood-lymph (1)
Bone marrow (1)
HEK-293T cell (1)
HeLa-229 cell (1)
T cell (1)
THP-1 cell (1)

Disease

Breast cancer (3)
Melanoma (3)
Acute leukemia (2)
Colon cancer (2)
Myocardial ischemia (2)
With bone lytic lesion (1)
HPV positive (1)
Colorectal carcinoma (1)
Amyotrophic lateral sclerosis (1)
Brain cancer (1)
Cardiovascular system disease (1)
Cell type cancer (1)
Childhood extraosseous osteosarcoma (1)
Chlamydia trachomatis infectious disease (1)
Cholangiocarcinoma (1)
Chronic bronchitis (1)
Colitis (1)
Congenital disorder of glycosylation (1)
Disease free (1)
Embryonal rhabdomyosarcoma (1)
Fibrosarcoma (1)
Frontotemporal dementia (1)
Head and neck cancer (1)
Hip osteoarthritis (1)
Listeriosis (1)
Low grade glioma (1)
Lung carcinoma (1)
Malaria (1)
Malignant mesothelioma (1)
Multiple myeloma (1)

Technology Type

Mass Spectrometry (96)
Shotgun proteomics (73)
Affinity purification coupled with mass spectrometry proteomics (18)
Mass spectrometry (8)
Bottom-up proteomics (7)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
Data-dependent acquisition (3)
NMR spectroscopy (2)
Data-independent acquisition (2)
Gel-based experiment (2)
ILLUMINA, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, Affymetrics_SNP_6.0- (1)
Illumina HiSeq 2000, Affymetrics_SNP_6.0-, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2000, Affymetrix SNP 6.0 (1)
Illumina HiSeq 2000, ILLUMINA, Illumina HiSeq 2500 (1)
Mass spectrometry assay (1)
NMR spectroscopy assay (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina HiSeq 2000 (3)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina Genome Analyzer IIx (2)
Illumina NovaSeq 6000 (2)
Gas Chromatography MS - positive (2)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (2)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS - positive - reverse phase (2)
Nuclear Magnetic Resonance (NMR) - (2)
Zymo Research (1)
PAXgene tubes (1)
Qiagen (1)
Nimble gene 12 x 135 k custom gene expression arrays (1)
NimbleGen MS2000 (1)
Illumina Genome Analyzer II (1)
NextSeq 2000 (1)
HiSeq X Ten (1)
Agilent 1290 Infinity II LC System (Agilent Technologies) coupled with a qTOF 6550 mass detector (1)
Orbitrap Fusion Lumos (1)
Bruker (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography Tandem MS (LC-MS/MS (Negative)) (1)
Liquid Chromatography Tandem MS (LC-MS/MS (Positive)) (1)
Q Exactive (1)

Publication Date

2015 (20)
2026 (15)
2021 (15)
2022 (15)
2025 (14)
2010 (12)
2020 (12)
2023 (10)
2019 (10)
2018 (9)
2016 (9)
2012 (9)
2011 (9)
2024 (8)
2013 (6)
2014 (5)
2007 (4)
2017 (4)
2009 (3)
2008 (3)
2006 (1)

CHEBI ID

CHEBI:15354 (6)
CHEBI:18257 (6)
CHEBI:25017 (6)
CHEBI:16737 (5)
CHEBI:16811 (5)
CHEBI:18186 (5)
CHEBI:18211 (5)
CHEBI:26271 (5)
CHEBI:27266 (5)
CHEBI:28044 (5)
CHEBI:30769 (5)
CHEBI:15344 (4)
CHEBI:15428 (4)
CHEBI:15891 (4)
CHEBI:16010 (4)
CHEBI:16040 (4)
CHEBI:16449 (4)
CHEBI:16857 (4)
CHEBI:16958 (4)
CHEBI:17053 (4)
CHEBI:17191 (4)
CHEBI:17268 (4)
CHEBI:17568 (4)
CHEBI:17754 (4)
CHEBI:22653 (4)
CHEBI:24898 (4)
CHEBI:25094 (4)
CHEBI:27570 (4)
CHEBI:28300 (4)
CHEBI:15318 (3)

Metabolite Name

Alanine (4)
Lysine (4)
Phenylalanine (4)
Proline (4)
Tyrosine (4)
Arginine (3)
Choline (3)
Choline (3)
Citrate (3)
Citrulline (3)
Creatinine (3)
Glutamine (3)
Histidine (3)
Isoleucine (3)
L-Histidine (3)
L-Proline (3)
L-Valine (3)
Leucine (3)
Methionine (3)
Ornithine (3)
Threonine (3)
Valine (3)
12,13-DiHOME (2)
Acetylcholine (2)
Adenosine (2)
Adipic acid (2)
D-glucose (2)
Guanine (2)
Inosine (2)
Isoleucine (2)

First Public Date

2014 (4)
2025 (1)
2021 (1)
2013 (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (45)
RNA-seq of coding RNA (9)
Methylation profiling by array (8)
Comparative genomic hybridization by array (4)
Unknown experiment type (3)
ChIP-seq (3)
ChIP-chip by tiling array (1)
Cell line - One-color microarray (1)
ChIP-chip by array (1)
Genotyping by array (1)
Transcription profiling by RT-PCR (1)
Other (1)
DNA-seq (1)
Genotyping by high throughput sequencing (1)
RNA-seq of total RNA (1)

Release Date

2022 (429)
2025 (404)
2023 (385)
2024 (377)
2021 (374)
2020 (297)
2019 (251)
2018 (232)
2015 (197)
2017 (197)
2016 (190)
2014 (158)
2013 (132)
2012 (125)
2011 (111)
2010 (88)
2026 (66)
2009 (59)
2008 (29)
2007 (22)
2006 (19)
2005 (7)
2004 (7)
2003 (6)
2002 (5)
2001 (2)
2000 (2)
1987 (1)

Lab affiliation

The Institute of Cancer Research (18)
The Institute of Cancer Research, London (9)
Wellcome Trust Sanger Institute (9)
Department of Chemistry, Imperial College London, Molecular Sciences Research Hub, London, W12 0BZ, UK The Francis Crick Institute, London, NW1 1AT, UK (4)
Institute of Cancer Research, London (4)
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid. (2)
Molecular Physiology & Biophysics, Wright Lab, University of Iowa, USA (2)
1. Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia 2. The University of Sydney, Discipline of Infectious Diseases & Immunology and Sydney Institute for Infectious Diseases, Camperdown, NSW 2050, Australia (1)
Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, School of Molecular and Cellular Bilogy, University of Leeds, LS2 9JT (1)
BCI Mass spectrometry Facility 1.02 & 1.03 1st floor Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ (1)
Baker Heart & Diabetes Institute (1)
Bavarian Center for Biomolecular Mass Spectrometry at Klinikum Rechts der Isar, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany (1)
Biological Sciences Dept, Mississippi State University, Mississippi State, 39762 (1)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria (1)
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) (1)
Dana Farber Cancer Institute Harvard Medical School Boston, Ma (1)
Department of Chemical and Biological Engineering, the University of Sheffield, Mappin Street, Sheffield, S1 3JD, United Kingdom (1)
Department of Chemistry, Imperial College London, Molecular Research Science Hub, 80 Wood Lane, London W12 0BZ, United Kingdom. The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom. (1)
Department of Medecine, Service of Pneumology, Université de Sherbrooke (1)
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA (1)
Department of Physiology and Pharmacology Oregon Health & Science University Portland, Oregon 97210, USA (1)
Division of Infection Medicine, BMC Faculty of Medicine Lund University Lund, Sweden (1)
Institute for Parasitology, University of Zurich, Zurich, Switzerland (1)
Institute of Cancer Research (1)
Institute of Cancer Research Wellcome Trust Sanger Institute (1)
Institute of Cancer Research, London & Wellcome Trust Sanger Institute (1)
Institute of Cancer Research, London & Wellcome Trust Sanger Institute, Cambridge (1)
Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald-Insel Riems,Germany (1)
Keele University (1)
Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China (1)

Tags

xref:PubMed:18359805 (1)
xref:PubMed:24486591 (1)
xref:PubMed:34292953 (1)
xref:PubMed:21472139 (1)
pathogen:bacterium (1)
pathogen (1)

Previous page
1 / 432
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 432
Next page

Sort by:

Relevance

Page size

A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95.

Not available

S-EPMC10477449 | biostudies-literature

Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity.

Not available

S-EPMC8244928 | biostudies-literature

Approaches to inhibiting oncogenic K-Ras.

Not available

S-EPMC7849769 | biostudies-literature

Ubiquitin-mediated modulation of necroptotic effector MLKL

We aimed to identify lysine (K) residues that are endogenously ubiquitylated upon TNF-induced necroptosis. To this end, we used a quantitative mass spectrometry-based approach. Briefly, MDFs were treated with TSZ or left untreated and protein lysates were digested with trypsin into peptides. Ubiquit...

ORGANISM(S): Mus musculus (Mouse)

2021-04-13 | PXD018857 | Pride

Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling.

Not available

S-EPMC7216516 | biostudies-literature

Depletion of phosphatidylinositol 4-phosphate at the Golgi translocates K-Ras to mitochondria.

Not available

S-EPMC6737909 | biostudies-literature

Mus musculus

Genome-wide analysis of tumor regression upon K-RAS inactivation

PRJNA174390 | ENA

Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon.

Not available

S-EPMC3532550 | biostudies-literature

Expression profiling of murine lung 70 days following exposure to fractionated or acute dose of 1.0 Gy 56Fe- particle irradiation

Irradiation of the K-rasLA1 mouse model with a fractionated dose of 1.0Gy 56Fe- particles increases the incidence of invasive carcinoma compared to unirradiated controls or those irradiated with an acute dose. Microarray profiling was perfromed on whole lungs from K-rasLA1 mice in order to determin...

ORGANISM(S): Mus musculus

2014-09-22 | E-GEOD-42233 | biostudies-arrayexpress

Genome-wide transcriptional responses of Escherichia coli K-12 to continuous osmotic and heat stresses.

Not available

S-EPMC2395010 | biostudies-literature

Previous page
1 / 432
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 432
Next page

Sort by:

Relevance

Page size

4316 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets